357 related articles for article (PubMed ID: 9007528)
1. Expression of mu-, delta- and kappa-opioid receptors in baculovirus-infected insect cells.
Obermeier H; Wehmeyer A; Schulz R
Eur J Pharmacol; 1996 Dec; 318(1):161-6. PubMed ID: 9007528
[TBL] [Abstract][Full Text] [Related]
2. Selective interference of beta-arrestin 1 with kappa and delta but not mu opioid receptor/G protein coupling.
Cheng ZJ; Yu QM; Wu YL; Ma L; Pei G
J Biol Chem; 1998 Sep; 273(38):24328-33. PubMed ID: 9733719
[TBL] [Abstract][Full Text] [Related]
3. Characterization of opioid receptors on smooth muscle cells from guinea pig stomach.
Zhang L; Gu ZF; Pradhan T; Jensen RT; Maton PN
Am J Physiol; 1992 Mar; 262(3 Pt 1):G461-9. PubMed ID: 1312793
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of adenylyl cyclase activity by mu and delta opioids in rat caudate putamen and nucleus accumbens.
Izenwasser S; Búzás B; Cox BM
J Pharmacol Exp Ther; 1993 Oct; 267(1):145-52. PubMed ID: 7901389
[TBL] [Abstract][Full Text] [Related]
5. Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys.
Ko MC; Lee H; Harrison C; Clark MJ; Song HF; Naughton NN; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2003 Jul; 306(1):179-86. PubMed ID: 12676881
[TBL] [Abstract][Full Text] [Related]
6. Binding of [3H][D-Ala2, MePhe4, Gly-ol5] enkephalin, [3H][D-Pen2, D-Pen5]enkephalin, and [3H]U-69,593 to airway and pulmonary tissues of normal and sensitized rats.
Bhargava HN; Villar VM; Cortijo J; Morcillo EJ
Peptides; 1997; 18(10):1603-8. PubMed ID: 9437722
[TBL] [Abstract][Full Text] [Related]
7. Ca2+ channel and adenylyl cyclase modulation by cloned mu-opioid receptors in GH3 cells.
Piros ET; Prather PL; Loh HH; Law PY; Evans CJ; Hales TG
Mol Pharmacol; 1995 May; 47(5):1041-9. PubMed ID: 7746271
[TBL] [Abstract][Full Text] [Related]
8. Opioid modulation of extracellular signal-regulated protein kinase activity is ras-dependent and involves Gbetagamma subunits.
Belcheva MM; Vogel Z; Ignatova E; Avidor-Reiss T; Zippel R; Levy R; Young EC; Barg J; Coscia CJ
J Neurochem; 1998 Feb; 70(2):635-45. PubMed ID: 9453557
[TBL] [Abstract][Full Text] [Related]
9. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
Schoffelmeer AN; Hogenboom F; Mulder AH
Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
[TBL] [Abstract][Full Text] [Related]
10. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A
Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845
[TBL] [Abstract][Full Text] [Related]
11. Opioid binding sites in the guinea pig and rat kidney: radioligand homogenate binding and autoradiography.
Dissanayake VU; Hughes J; Hunter JC
Mol Pharmacol; 1991 Jul; 40(1):93-100. PubMed ID: 1649966
[TBL] [Abstract][Full Text] [Related]
12. Characterization of mu, kappa, and delta opioid binding in amphibian whole brain tissue homogenates.
Newman LC; Sands SS; Wallace DR; Stevens CW
J Pharmacol Exp Ther; 2002 Apr; 301(1):364-70. PubMed ID: 11907194
[TBL] [Abstract][Full Text] [Related]
13. Regional, developmental, and cell cycle-dependent differences in mu, delta, and kappa-opioid receptor expression among cultured mouse astrocytes.
Stiene-Martin A; Zhou R; Hauser KF
Glia; 1998 Mar; 22(3):249-59. PubMed ID: 9482211
[TBL] [Abstract][Full Text] [Related]
14. Glial growth is regulated by agonists selective for multiple opioid receptor types in vitro.
Stiene-Martin A; Hauser KF
J Neurosci Res; 1991 Aug; 29(4):538-48. PubMed ID: 1665190
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats.
Suzuki T; Mori T; Tsuji M; Maeda J; Kishimoto Y; Misawa M; Nagase H
Eur J Pharmacol; 1997 Apr; 324(1):21-9. PubMed ID: 9137909
[TBL] [Abstract][Full Text] [Related]
16. Evidence for the presence of mu- and kappa- but not of delta-opioid sites in the human fetal brain.
Magnan J; Tiberi M
Brain Res Dev Brain Res; 1989 Feb; 45(2):275-81. PubMed ID: 2540923
[TBL] [Abstract][Full Text] [Related]
17. Comparison of cardiovascular responses to intra-hippocampal mu, delta and kappa opioid agonists in spontaneously hypertensive rats and isolation-induced hypertensive rats.
Shen S; Ingenito AJ
J Hypertens; 1999 Apr; 17(4):497-505. PubMed ID: 10404951
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of KT-90 using cloned mu-, delta- and kappa-opioid receptors.
Katsumata S; Ienaga Y; Minami M; Nakagawa T; Kanematsu K; Satoh M
Eur J Pharmacol; 1996 Oct; 312(3):349-55. PubMed ID: 8894618
[TBL] [Abstract][Full Text] [Related]
19. Autoradiographic distribution of mu-, delta- and kappa 1-opioid stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in human frontal cortex and cerebellum.
Platzer S; Winkler A; Schadrack J; Dworzak D; Tölle TR; Zieglgänsberger W; Spanagel R
Neurosci Lett; 2000 Apr; 283(3):213-6. PubMed ID: 10754225
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum.
Mitrovic I; Napier TC
J Pharmacol Exp Ther; 1995 Mar; 272(3):1260-70. PubMed ID: 7891342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
